In October, John Penglis will be made an Honorary Fellow of Griffith University's Institute for Glycomics in recognition of his ten years support for the research being conducted there.
Griffith University will celebrate more than its Open Day this weekend. It will also mark 20 years since the world’s first anti-flu drug Relenza was discovered by a team headed by Professor Mark von Itzstein, now Director of Griffith’s Institute for Glycomics on the Gold Coast campus. Groundbreaking discovery Relenza is considered one of Australia’s […]
Griffith University has completed a partnership agreement with the Australian infectious disease therapy development company BioDiem Ltd to develop a more soluble form of the a broad-spectrum antimicrobial compound.
Director of Griffith University’s Institute for Glycomics, Professor Mark von Itzstein says there has been an important research discovery which may pave the way to new treatments for leukaemia.